FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

J&J culls apps for move to cloud

Free Newsletter

FierceBiotech IT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Sign up today!



Tools

Sebastian Piotrowski is cautious about data security in cloud computing. The systems engineering lead at Johnson & Johnson says the company processes data using the Amazon Web Services cloud but keeps the data fully obscured.

His current cloud efforts are geared at managing the disruption of peak-and-valley computing requirements. He says he is currently working with business partners to move applications out of the J&J grid and into the cloud in an ongoing proof of concept, according to a SearchCloudComputing.com article. A gradual grid-to-cloud applications migration is also underway at J&J's Pharma R&D unit, as reported earlier.

Migration decisions are made using the simplest of business math at J&J: comparing grid vs. cloud costs. Bandwidth and storage requirements drive the calculation.

Cloud computing remains a small piece of the J&J IT pie, but Piotrowski says expansion is just a matter of time. Hybrid models, in fact, which permit application scaling out of the grid and into the cloud, "are too economical to avoid," the article says.

- read the article
- here's our earlier coverage

Related Articles:
The stormy debate on cloud computing security
Cloud experts agree: choose carefully


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:

More stories about Data Security   Proof Of Concept   Hybrid Models   Migration   biotech cloud computing